This inventor holds 2 USPTO granted patents and 1 published patent application and 1 EPO patent. Top assignee: H. Lundbeck A/s. Active years: 2009-2023.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2009-2023
Title: Krestian Larsen: Pharmaceutical Patent Inventor
Introduction
Krestian Larsen is an inventor based in Ringsted, Denmark. His patent work includes pharmaceutical compounds and potential treatments for conditions involving specific ion channels and receptors. He is associated with H. Lundbeck A/S and has 2 patents.
Latest Patents
Larsen’s listed patents concern compounds investigated for their potential therapeutic applications.
“Alcohol derivatives as KV7 potassium channel openers” describes novel compounds that activate Kv7 potassium channels. The invention also covers pharmaceutical compositions containing these compounds and their use in treating disorders responsive to Kv7 channel activation.
“2,3-dihydroindole compounds” relates to compounds described by a chemical formula, with variables defined in the patent claims. The compounds are presented as useful for treating diseases in which the D4 receptor and/or a 5-HT receptor is implicated.
Career Highlights
Larsen’s patent portfolio reflects work in medicinal chemistry and pharmaceutical research. The inventions focus on compounds that may act on biological targets relevant to therapeutic development.
Collaborations
Larsen’s listed coworkers include Shu Hui Chen and Niels Mørk. His work is associated with H. Lundbeck A/S, a pharmaceutical company.
Conclusion
Krestian Larsen’s two listed patents highlight his contributions to pharmaceutical inventions involving Kv7 potassium channels and receptor-targeting compounds.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile